Cellebrite (נאסד"ק: CLBT) מובילה עולמית בפתרונות בינה דיגיטלית ("DI") למגזר הציבורי והפרטי, הודיעה היום כי תדווח על תוצאותיה הכספיות לרבעון השני של 2023 לפני פתיחת השוק ביום שלישי, 8 באוגוסט 2023.
Cellebrite to Report Second-Quarter 2023 Financial Results on August 8, 2023
PETAH TIKVA, Israel and TYSONS CORNER, Va., July 12, 2023 (GLOBE NEWSWIRE):
Cellebrite (NASDAQ: CLBT), a global leader in Digital Intelligence (“DI”) solutions for the public and private sectors, today announced it will report its second-quarter 2023 financial results before market open on Tuesday, August 8, 2023.
Later that same morning, Cellebrite will host a live conference call and webcast to review the Company’s financial results for the first quarter of 2023 and discuss its full-year 2023 outlook. Pertinent details include
Date: | Tuesday, August 8, 2023 |
Time: | 8:30 a.m. ET |
Call-In Number: | 203-518-9848 |
Conference ID: | CLBTQ223 |
Event URL: | https://investors.cellebrite.com/events/event-details/cellebrite-q2-23-earnings |
Live Webcast URL: | https://edge.media-server.com/mmc/p/f896bks4 |
In conjunction with the conference call and webcast, historical financial tables and supplemental data will be available on the quarterly results section of Company’s investor relations website at https://investors.cellebrite.com/financial-information/quarterly-results. A transcript of the call will be added to this page along with access to the replay of the call.
About Cellebrite
Cellebrite’s (NASDAQ: CLBT) mission is to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. We are a global leader in Digital Intelligence solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Trusted by thousands of leading agencies and companies worldwide, Cellebrite’s Digital Intelligence platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. To learn more, visit us at www.cellebrite.com and https://investors.cellebrite.com.